Jim Hampe serves as chief business officer at Faze Medicines. Jim brings two decades of biotech experience to Faze. He currently advises clients on business development strategy and execution and previously served in business development and operational roles at IFM Therapeutics, Biogen, Archemix, Novartis Institutes for BioMedical Research, and Anterogen. He started his career as a research associate at Beth Israel Deaconess Medical Center. Jim received his MBA from the Tuck School of Business at Dartmouth College.
Jim agreed that his 5-year-old son could choose a dog name a year before actually bringing home a puppy. His family now enjoys spending time with Lemon, their entirely black dog.